Targeting Potential of Zinc Oxide Nanoparticles and Finasteride-Loaded Nano Lipidic Carriers-Infused Topical Gel - In Vitro and In Vivo Skin Permeation Studies

    Veintramuthu Sankar, Rajandurai Baby Roselin, S Pranav Raghavenndra Raghavenndra, Munusamy Nithyanth, Antony Justin
    Image of study
    TLDR Nanocarriers in gel may reduce side effects of oral hair loss treatments.
    The document discusses a study on the use of Finasteride (FIN), an inhibitor of the 5α reductase enzyme, in a topical gel form for treating androgenic alopecia. The study explores the use of lipidic nanocarriers to improve follicular permeability and solubility. The document suggests that these nanocarriers could potentially offer numerous benefits, including reducing the severe systemic adverse effects associated with oral treatments for androgenic alopecia. However, the document does not provide specific data or results from the study.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 1 year ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community Bile Acid-Mediated DHT Dysregulation Hypothesis

      in Research/Science  13 upvotes 1 year ago
      Elevated bile acids can inhibit the enzyme AKR1C2, leading to increased DHT levels, which may accelerate hair loss in those predisposed to androgenetic alopecia. Treatments mentioned include topical minoxidil and finasteride.

      community My Theory Of Androgenic Alopecia

      in Research/Science  19 upvotes 4 months ago
      Hair loss is linked to cellular physiology and the IGF-1 to TGF-B1 ratio, not just androgen sensitivity. The theory lacks evidence, while finasteride and minoxidil are effective treatments.

      community Testosterone and Estradiol levels on 1 mg/day dutasteride

      in Finasteride/Dutasteride  42 upvotes 5 months ago
      A 30-year-old man experienced significant hair regrowth and improved libido after using finasteride and dutasteride for androgenetic alopecia, with no adverse effects. He plans to reduce dutasteride dosage when trying to conceive and has been using topical minoxidil since 2015.

    Related Research

    8 / 8 results